Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: Substrate recognition motifs and affinity for trypanocidal drugs

Molecular Pharmacology

Volumn 56, Issue 6, 1999, Pages 1162-1170

  De Koning, Harry P ^a,b   Jarvis, Simon M ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTITRYPANOSOMAL AGENT; FORMYCIN; GANCICLOVIR; PYRIMIDINE DERIVATIVE; RIBAVIRIN; TUBERCIDIN;

ARTICLE; DRUG EFFECT; ENZYME SUBSTRATE; HYDROGEN BOND; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI; TRYPANOSOMIASIS;

EID: 0032732283     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.6.1162     Document Type: Article

References (40)

1. Bacchi CJ (1993) Resistance to clinical drugs in African trypanosomes. Parasitol Today 9:190-193.
2. Bacchi CJ, Garofalo J, Ciminelli M, Rattendi D, Goldberg B, McCann PP and Yarlett N (1993) Resistance to DL-α-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense: Role of S-adenosylmethionine. Biochem Pharmacol 46:471-481.
3. Bacchi CJ, Nathan HC, Livingston T, Valladares G, Saric M, Sayer PD, Njogu AR and Clarkson AB Jr (1990) Differential susceptibility to D,L-α-difluoromethylornithine in clinical isolates of T. brucei rhodesiense. Antimicrob Agents Chemother 34:1183-1188.
4. Barrett MP, Zhang ZQ, Denise H, Giroud C and Baltz T (1995) A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Mol Biochem Parasitol 73:223-229.
5. Bzowska A, Kulikowska E and Shugar D (1992) Formycins A and B and some analogues: Selective inhibitors of bacterial (Escherichia coli) purine nucleoside phosphorylase. Biochim Biophys Acta 1120:239-247.
6. Carter NS, Berger BJ and Fairlamb AH (1995) Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J Biol Chem 270:28153-28157.
7. Carter NS and Fairlamb AH (1993) Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature (Lond) 361:173-175.
8. Cass CE (1995) Nucleoside transport, in Drug Transport in Antimicrobial Therapy and Anticancer Therapy (Georgopapadakou NH ed) pp 403-451, Marcel Dekker, New York.
9. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
10. Chenon M-T, Pugmire RJ, Grant DM, Panzica RP and Townsend LB (1975) Carbon-13 magnetic resonance. XXV. A basic set of parameters for the investigation of tautomerism in purines established from carbon-13 magnetic resonance studies using certain purines and pyrrolo[2,3-d]pyrimidines. J Am Chem Soc 97:4627-4642.
11. Defrise-Quertain F, Fraser-L'Hostis C, Coral D and Deshusses J (1996) Kinetic study of the plasma-membrane potential in procyclic and bloodstream forms of Trypanosoma brucei brucei using the fluorescent probe bisoxonol. Biochem J 314:595-601.
12. De Koning HP and Jarvis SM (1997a) Hypoxanthine uptake through a novel purine-selective nucleobase transporter in Trypanosoma brucei brucei procyclics is driven by protonmotive force. Eur J Biochem 247:1102-1110.
13. De Koning HP and Jarvis SM (1997b) Purine nucleobase transport in bloodstream forms of Trypanosoma brucei brucei is mediated by two novel transporters. Mol Biochem Parasitol 89:245-258.
14. De Koning HP and Jarvis SM (1998) A highly selective, high-affinity transporter for uracil in Trypanosoma brucei brucei; evidence for proton-dependent transport. Biochem Cell Biol, in press.
15. De Koning HP, Watson CJ and Jarvis SM (1998) Characterization of a nucleoside/ proton symporter in procyclic Trypanosoma brucei brucei. J Biol Chem 273:9486-9494.
16. Dukes P (1984) Arsenic and old taxa: Subspeciation and drug sensitivity in Trypanosoma brucei. Trans R Soc Trop Med Hyg 78:711-725.
17. Eads JC, Scapin G, Xu Y, Grubmeyer C and Sacchettini JC (1994) The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP. Cell 78:325-334.
18. Griffith DA and Jarvis SM (1996) Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta 1288:405-443.
19. Hammond DJ and Gutteridge WE (1984) Purine and pyrimidine metabolism in the trypanosomatidae. Mol Biochem Parasitol 13:243-261
20. 2. Inorg Chem 32:6095-6101.
21. Hassan HF and Coombs GH (1988) Purine and pyrimidine metabolism in parasitic protozoa. Microbiol Rev 54:47-84.
22. Hunter CA, Singh J and Thornton JM (1991) π-π interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins. J Mol Biol 218:837-846.
23. Jarvis SM, Thorn JA and Glue P (1998) Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters. Br J Pharmacol 123:1587-1592.
24. Lanham SM (1968) Separation of trypanosomes from the blood of infected rats and mice by anion-exchangers. Nature (Lond) 218:1273-1274.
25. Kayembe D and Wéry M (1972) Observations sur la sensibilité aux diamidines de souches de Trypanosoma gambiense récemment isolées en République du Zaïre. Ann Soc Belg Med Trop 52:1-8.
26. Koellner G, Luić M, Shugar D, Saenger W and Bzowska A (1998) Crystal structure of the ternary complex of E. coli purine nucleoside phosphorylase with formycin B, a structural analogue of the substrate inosine, and phosphate (sulphate) at 2.1 Å resolution. J Mol Biol 280:153-166.
27. Kuzoe FAS (1993) Current situation of African trypanosomiasia. Acta Trop 54:153-162.
28. Pepin J and Milford F (1994) The treatment of human African trypanosomiasis. Adv Parasitol 33:1-47.
29. Plagemann PGW, Wohlhueter RM and Woffendin C (1988) Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta 947:405-443.
30. Rastelli G, Costantino L and Albasini A (1997) A model for the interaction of substrates and inhibitors with xanthine oxidase. J Am Chem Soc 119:3007-3016.
31. Ross CA and Barns AM (1996) Alteration to one of three adenosine transporters is associated with resistance to Cymelarsan in Trypanosoma evansi. Parasitol Res 82:183-188.
32. Schumacher MA, Carter D, Roos DS, Ullmann B and Brennan RG (1996) Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop. Nat Struct Biol 3:881-887
33. Somoza JR, Chin MS, Focia PJ, Wang CC and Fletterick RJ (1996) Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus. Biochemistry 35:7032-7040.
34. Somoza JR, Skillman AG, Mungala NR, Oshiro CM, Knegtel RMA, Mpoke S, Fletterick RJ, Kuntz ID and Wang CC (1998) Rational design of novel antimicrobials: blocking purine salvage in a parasitic protozoan. Biochemistry 37:5344-5348.
35. Sundaram M, Yao SYM, Ng AML, Griffiths M, Cass CE, Baldwin SA and Young JD (1998) Chimeric constructs beween human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem 278:21519-21525.
36. Tye C-K, Kasinathan G, Barrett MP, Brun R, Doyle VE, Fairlamb AH, Weaver R and Gilbert IH (1998) An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes. Bioorg Med Chem Lett 8:811-816.
37. Vos S, Parry RJ, Burns MR, De Jersey J and Martin JL (1998) Structures of free and complexed forms of Escherichta coli xanthine-guanine phosphoribosyltransferase. J Mol Biol 282:875-889.
38. +-nucleoside transporter. J Biol Chem 274:2298-2302.
39. +-nucleoside transporter. Mol Pharmacol 55:234-240.
40. Wery, M (1991) Therapy for African trypanosomiasis. Curr Opin Infect Dis 4:838-843.